Search Results - "BUATTI, J. M"

Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial by Petronek, M. S., Bodeker, K. L., Lee, C. Y., Teferi, N., Eschbacher, K. L., Jones, K. A., Loeffler, B. T., Smith, B. J., Buatti, J. M., Magnotta, V. A., Allen, B. G.

“…Background Pharmacological ascorbate (intravenous delivery reaching plasma concentrations ≈ 20 mM; P-AscH − ) has emerged as a promising therapeutic strategy…”
Get full text

Role of radiotherapy in adenoid cystic carcinoma of the head and neck by Iseli, T A, Karnell, L H, Graham, S M, Funk, G F, Buatti, J M, Gupta, A K, Robinson, R A, Hoffman, H T

“…This study retrospectively reviewed 183 cases of adenoid cystic carcinoma treated over 40 years. The local recurrence free survival rate was 68.2 per cent at…”
Get more information

Analysis of risk factors associated with radiosurgery for vestibular schwannoma by FOOTE, Kelly D, FRIEDMAN, William A, BUATTI, John M, MEEKS, Sanford L, BOVA, Frank J, KUBILIS, Paul S

“…The aim of this study was to identify factors associated with delayed cranial neuropathy following radiosurgery for vestibular schwannoma (VS or acoustic…”
Get full text

Benign meningiomas: primary treatment selection affects survival by Condra, K S, Buatti, J M, Mendenhall, W M, Friedman, W A, Marcus, Jr, R B, Rhoton, A L

“…To examine the effect of primary treatment selection on outcomes for benign intracranial meningiomas at the University of Florida. For 262 patients, the impact…”
Get more information

A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis by Auchter, R M, Lamond, J P, Alexander, E, Buatti, J M, Chappell, R, Friedman, W A, Kinsella, T J, Levin, A B, Noyes, W R, Schultz, C J, Loeffler, J S, Mehta, M P

“…Recent randomized trials of selected patients with single brain metastasis comparing resection followed by whole-brain radiotherapy (WBRT) to WBRT alone have…”
Get more information

Magnetite nanoparticles as a kinetically favorable source of iron to enhance GBM response to chemoradiosensitization with pharmacological ascorbate by Petronek, M.S., Teferi, N., Caster, J.M., Stolwijk, J.M., Zaher, A., Buatti, J.M., Hasan, D., Wafa, E.I., Salem, A.K., Gillan, E.G., St – Aubin, J.J., Buettner, G.R., Spitz, D.R., Magnotta, V.A., Allen, B.G.

“…Ferumoxytol (FMX) is an FDA-approved magnetite (Fe3O4) nanoparticle used to treat iron deficiency anemia that can also be used as an MR imaging agent in…”
Get full text

Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients by Mapuskar, K.A., Vasquez Martinez, G., Pulliam, C.F., Petronek, M.S., Steinbach, E.J., Monga, V., Furqan, M., Jetton, J.G., Saunders, D.P., Pearce, A., Davidson, S., Pitre, L., Dunlap, N.E., Fairbanks, R., Lee, C.M., Mott, S.L., Bodeker, K.L., Cl, Huang, Buatti, J.M., Anderson, C.M., Beardsley, R.A., Holmlund, J.T., Zepeda-Orozco, D., Spitz, D.R., Allen, B.G.

“…Head and neck squamous cell carcinoma (HNSCC) patients treated with high-dose cisplatin concurrently with radiotherapy (hdCis-RT) commonly suffer kidney injury…”
Get full text

Radiotherapy for pituitary adenoma: long-term outcome and sequelae by McCord, M W, Buatti, J M, Fennell, E M, Mendenhall, W M, Marcus, Jr, R B, Rhoton, A L, Grant, M B, Friedman, W A

“…To review outcome and treatment sequelae in patients treated with external beam radiotherapy for pituitary adenomas. One hundred forty-one patients with…”
Get more information

Analysis of treatment failure after radiosurgery for arteriovenous malformations by ELLIS, T. L, FRIEDMAN, W. A, BOVA, F. J, KUBILIS, P. S, BUATTI, J. M

“…The aim of this study was to evaluate the causes of treatment failure in patients with arteriovenous malformations (AVMs) who underwent radiosurgery, which is…”
Get full text

The University of Florida frameless high-precision stereotactic radiotherapy system by Bova, F J, Buatti, J M, Friedman, W A, Mendenhall, W M, Yang, C C, Liu, C

“…To develop and test a system for high precision fractionated stereotactic radiotherapy that separates immobilization and localization devices. Patient…”
Get more information

The risk of hemorrhage after radiosurgery for arteriovenous malformations by FRIEDMAN, W. A, BLATT, D. L, BOVA, F. J, BUATTI, J. M, MENDENHALL, W. M, KUBILIS, P. S

“…Two hundred and one patients with arteriovenous malformations (AVMs) treated radiosurgically between May 1988 and February 1995 are analyzed in this study…”
Get full text

Image localization for frameless stereotactic radiotherapy by Meeks, S L, Bova, F J, Wagner, T H, Buatti, J M, Friedman, W A, Foote, K D

“…Infrared light-emitting diodes (IRLEDs) have been used for optic-guided stereotactic radiotherapy localization at the University of Florida since 1995. The…”
Get more information

Preliminary results of linear accelerator radiosurgery for acoustic schwannomas by MENDENHALL, W. M, FRIEDMAN, W. A, BUATTI, J. M, BOVA, F. J

“…In this paper the authors evaluate the results of linear accelerator (LINAC)-based stereotactic radiosurgery for acoustic schwannomas. Fifty-six patients…”
Get full text

Linac radiosurgery for benign meningiomas by Shafron, D H, Friedman, W A, Buatti, J M, Bova, F J, Mendenhall, W M

“…To review outcomes for patients treated with linac radiosurgery for benign meningiomas. Between January 1989 and July 1997, 70 patients with 76 meningiomas…”
Get more information

Potential clinical efficacy of intensity-modulated conformal therapy by Meeks, S L, Buatti, J M, Bova, F J, Friedman, W A, Mendenhall, W M, Zlotecki, R A

“…The purpose of this study was to examine the potential benefit of using intensity-modulated conformal therapy for a variety of lesions currently treated with…”
Get more information

Calculation of cranial nerve complication probability for acoustic neuroma radiosurgery by Meeks, S L, Buatti, J M, Foote, K D, Friedman, W A, Bova, F J

“…Estimations of complications from stereotactic radiosurgery usually rely simply on dose-volume or dose-diameter isoeffect curves. Due to the sparse clinical…”
Get more information

Linear accelerator radiosurgery for nonacoustic schwannomas by Mabanta, S R, Buatti, J M, Friedman, W A, Meeks, S L, Mendenhall, W M, Bova, F J

“…To analyze the results of nonacoustic schwannomas treated with linear accelerator stereotactic radiosurgery. Between August 1989 and October 1997, 18 patients…”
Get more information

A high-precision system for conformal intracranial radiotherapy by Tome, W A, Meeks, S L, Buatti, J M, Bova, F J, Friedman, W A, Li, Z

“…Currently, optimally precise delivery of intracranial radiotherapy is possible with stereotactic radiosurgery and fractionated stereotactic radiotherapy. We…”
Get more information

Medulloblastoma: time-dose relationship based on a 30-year review by del Charco, J O, Bolek, T W, McCollough, W M, Maria, B L, Kedar, A, Braylan, R C, Mickle, J P, Buatti, J M, Mendenhall, N P, Marcus, Jr, R B

“…Time-dose relationships have proven important in many cancer sites. This study evaluates the time factors involved in the successful postoperative radiotherapy…”
Get more information

Preliminary experience with frameless stereotactic radiotherapy by Buatti, J M, Bova, F J, Friedman, W A, Meeks, S L, Marcus, Jr, R B, Mickle, J P, Ellis, T L, Mendenhall, W M

“…To report initial clinical experience with a novel high-precision stereotactic radiotherapy system. Sixty patients ranging in age from 2 to 82 years received a…”
Get more information